Statement: the route of administration for both interventions in the primary trial is a topical skin cream.
Primary_evidence: INTERVENTION 1:    Celecoxib   Randomized to receive celecoxib daily for 12 months INTERVENTION 2:    Placebo   Randomized to receive placebo daily for 12 months